Neoadjuvant Pembrolizumab Plus Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT05302011 · COMPLETED
Trial details
- NCT number
- NCT05302011
- Sponsor
- Peking Union Medical College Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2023-03-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.